Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease-Reference-Cited by-同舟云学术

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease

Published:2010-02-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Donnellan Clare¹,Preston Cathy²,Moayyedi Paul³,Sharma Nav⁴

Affiliation:

1. University of Leeds; Gastroenterology; Room 190A, B Floor Clarendon Wing, LGI Leeds West Yorkshire UK LS1 3EX

2. St James University Hospital; Gastroenterology; Beckett Street Leeds UK LS9 7TF

3. McMaster University; Department of Medicine, Division of Gastroenterology; Room 4W8E 1200 Main Street West Hamilton Ontario Canada L8N 3Z5

4. Queen Elizabeth Hospital; Gastroenterology Unit; Edgbaston Birmingham UK B15 2TH

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003245.pub3/fullpdf

Reference201 articles.

1. Comparison between omeprazole and ranitidine in medium-term treatment of reflux oesophagitis;Angelini;Gionale Itialiano Endoscopica Digestica,1993

2. Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment;Annibale;Hepato-Gastroenterology,1998

3. Full dose H2 receptor antagonist prophylaxis does not prevent relapse of reflux oesophagitis;Armstrong;Gut,1989

4. Lansoprazole maintains healing in patients with reflux esophagitis;Baldi;Gastroenterology,1996

5. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis;Baldi;American Journal of Gastroenterology,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbid patient with GERD and cardiovascular disease receiving antiplatelet therapy. The possibilities of choosing a proton pump inhibitor on a case study;Medical Council;2019-10-11

2. Factores de riesgo asociados a recaída de enfermedad por reflujo gastroesofágico en pacientes de primer nivel de atención exitosamente tratados con inhibidor de la bomba de protones;Revista de Gastroenterología de México;2017-04

3. Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor;Revista de Gastroenterología de México (English Edition);2017-04

4. The Indications, Applications, and Risks of Proton Pump Inhibitors;Deutsches Ärzteblatt international;2016-07-11

5. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device;Surgical Endoscopy;2015-11-04